Sanofi-Aventis S.A. ADR (SNY)
55.55 -0.27 (-0.48%) 15:37 ET [NASDAQ]
55.54 x 43 55.57 x 105
Realtime by (Cboe BZX)
55.54 x 43 55.57 x 105
Realtime 54.91 -0.91 (-1.63%) 08:34 ET
for Mon, Mar 31st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 47,921,880 | 50,266,340 | 47,821,850 | 46,347,940 | 42,686,610 |
| Cost of Goods | 14,289,130 | 15,407,620 | 14,429,050 | 14,498,890 | 13,886,940 |
| Gross Profit | 33,632,750 | 34,858,720 | 33,392,800 | 31,849,050 | 28,799,670 |
| Operating Expenses | 25,413,250 | 25,265,840 | 22,672,470 | 22,004,180 | 12,412,030 |
| Operating Income | 8,219,629 | 9,593,504 | 10,720,380 | 9,845,758 | 16,388,580 |
| Interest Expense | 1,161,093 | 1,421,060 | 463,584 | 435,381 | 445,497 |
| Other Income | 254,296 | -555,217 | 795,469 | -138,423 | 235,313 |
| Pre-tax Income | 7,312,832 | 7,617,228 | 11,052,265 | 9,271,954 | 16,178,396 |
| Income Tax | 1,302,848 | 1,733,845 | 2,113,521 | 1,843,270 | 2,070,990 |
| Net Income Continuous | 6,009,983 | 5,883,383 | 8,938,742 | 7,428,685 | 14,107,410 |
| Net Income Discontinuous | 69,254 | N/A | N/A | N/A | N/A |
| Minority Interests | 62,762 | 38,963 | 119,057 | 66,254 | 41,123 |
| Net Income | $6,016,476 | $5,844,420 | $8,819,686 | $7,362,432 | $14,066,280 |
| EPS Basic Total Ops | 2.40 | 2.33 | 3.52 | 2.94 | 5.61 |
| EPS Basic Continuous Ops | 2.40 | 2.35 | 3.57 | 2.97 | 5.63 |
| EPS Basic Discontinuous Ops | 0.03 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 2.40 | 2.33 | 3.51 | 2.93 | 5.58 |
| EPS Diluted Continuous Ops | 2.39 | 2.34 | 3.56 | 2.95 | 5.60 |
| EPS Diluted Discontinuous Ops | 0.03 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 3.85 | 4.39 | 4.35 | 3.88 | 3.35 |
| EBITDA(a) | $12,100,040 | $14,779,890 | $14,323,690 | $13,810,330 | $20,596,810 |